End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
593,160 COP | -2.35% |
|
-3.77% | -2.55% |
Jul. 03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
Jul. 03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- Charts Johnson & Johnson